Stay updated on Hepatic Impairment Impact on Risdiplam: Clinical Trial
Sign up to get notified when there's something new on the Hepatic Impairment Impact on Risdiplam: Clinical Trial page.

Latest updates to the Hepatic Impairment Impact on Risdiplam: Clinical Trial page
- Check3 days agoChange DetectedNo substantive changes are visible between the two screenshots; the study details and page sections remain unchanged.SummaryDifference0.4%

- Check10 days agoNo Change Detected
- Check32 days agoChange DetectedCore updates include a status/operational notice about funding and a new resource entry (Spinal muscular atrophy), plus a version bump to v3.2.0. The funding notice is the most impactful change for users.SummaryDifference3%

- Check39 days agoChange DetectedUpdate the page version from v3.0.2 to v3.1.0, indicating a newer release. Overall meaning remains the same with an explicit version bump.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, and the Back to Top element has been removed.SummaryDifference0.2%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check68 days agoChange DetectedThe web page has updated its core content by adding a facility name and location, as well as introducing new topics related to spinal muscular atrophy and MedlinePlus Genetics, while removing several previous topics and location details.SummaryDifference2%

Stay in the know with updates to Hepatic Impairment Impact on Risdiplam: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Hepatic Impairment Impact on Risdiplam: Clinical Trial page.